These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7022960)

  • 21. How can HLA matching improve kidney graft survival?
    van Rood JJ; Persijn GG; Lansbergen Q; Cohen B; van Leeuwen A; Bradley BA
    Proc Eur Dial Transplant Assoc; 1979; 16():297-304. PubMed ID: 398498
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood transfusions and kidney transplants: remaining controversies.
    Opelz G; Mickey MR; Terasaki PI
    Transplant Proc; 1981 Mar; 13(1 Pt 1):136-41. PubMed ID: 7022811
    [No Abstract]   [Full Text] [Related]  

  • 23. Human leukocyte antigen matching in renal transplantation: review and current status.
    Zmijewski CM
    J Surg Res; 1985 Jan; 38(1):66-87. PubMed ID: 3917516
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 25. Pretransplant immunologic considerations.
    Thorsby E; Ettenger R; Garovoy M
    Transplant Proc; 1984 Dec; 16(6):1649-53. PubMed ID: 6390879
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of accelerated failures by transfusion.
    Terasaki PI; Perdue S; Ayoub G; Iwaki Y; Park MS; Mickey MR
    Transplant Proc; 1982 Jun; 14(2):251-9. PubMed ID: 7051463
    [No Abstract]   [Full Text] [Related]  

  • 27. HLA-DR3 associated with improved kidney transplant survival.
    Cicciarelli JC; Perdue S; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):308-10. PubMed ID: 7051472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relevance of experimental studies to clinical practice in renal transplantation.
    Morris PJ; Dallman M; Hutchinson IV; McWhinnie DL; Ting A; Wood KJ
    Prog Clin Biol Res; 1986; 224():69-86. PubMed ID: 3540996
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved kidney graft survival in nontransfused recipients.
    Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):149-52. PubMed ID: 3547811
    [No Abstract]   [Full Text] [Related]  

  • 30. Probable role of suppressor cells and factors in kidney graft survival.
    Bensussan A; Klatzmann D; Gluckman JC; Kalil J; Dausset J; Sasportes M
    Transplant Proc; 1982 Sep; 14(3):584-7. PubMed ID: 6217608
    [No Abstract]   [Full Text] [Related]  

  • 31. Significant effect of HLA-DRB1 typing by linkage disequilibrium on kidney graft outcome.
    Ichikawa Y; Hashimoto M; Nojima M; Sata M; Fujimoto N; Kyo M; Ishibashi M; Ohshima S; Amemiya H; Fukunishi T
    Transplant Proc; 1993 Aug; 25(4):2707-9. PubMed ID: 8356724
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors influencing first cadaver renal allograft survival.
    Jonasson O; Moses V
    Transplant Proc; 1981 Mar; 13(1 Pt 1):44-7. PubMed ID: 7022869
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood transfusion in renal transplantation.
    Persijn GG
    Ann Clin Res; 1981; 13(4-5):215-23. PubMed ID: 7039481
    [No Abstract]   [Full Text] [Related]  

  • 34. Perioperative cyclosporine: interaction with multifactorial variables and effect on allograft function.
    Mendez R; Koussa N; Alanizi A; Mendez RG; Iwaki Y; Bogaard TP; Khetan U
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):12-5. PubMed ID: 3515677
    [No Abstract]   [Full Text] [Related]  

  • 35. Simulation study of kidney allocation to recipients with a zero mismatch for HLA-DRB1.
    Ichikawa Y; Hashimoto M; Hanafusa T; Kyo M; Kinoshita T; Yamasaki M; Ihara H; Fukunishi T; Nagano S
    Transplantation; 1994 Jul; 58(1):120-1. PubMed ID: 8036702
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and experimental transplantation. Kidney.
    Transplant Proc; 1983 Mar; 15(1 Pt 2):1031-217. PubMed ID: 6340293
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.